High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium.

Leavis, Helen L

High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium. [electronic resource] - Journal of clinical microbiology Mar 2006 - 1059-64 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0095-1137

10.1128/JCM.44.3.1059-1064.2006 doi


Base Sequence
Ciprofloxacin--pharmacology
Cross Infection--drug therapy
DNA Gyrase--genetics
DNA Topoisomerase IV--genetics
DNA, Bacterial--genetics
Drug Resistance, Bacterial--genetics
Enterococcus faecium--drug effects
Genes, Bacterial
Genomic Islands
Genotype
Gram-Positive Bacterial Infections--drug therapy
Humans
Models, Biological
Point Mutation
Virulence--genetics